Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DAR✓SelectedUSD · DARGSK vs DAR performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs DAR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
DAR return
-8.5%
Excess return
+55.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioDARExcessAlpha
1D-2.7%+2.9%-5.7%-2.9%
7D-4.2%-0.9%-3.3%-4.1%
30D-7.5%+13.0%-20.5%-8.2%
3M-3.3%+15.0%-18.3%-4.2%
6M-9.3%+26.8%-36.2%-10.9%
YTD+1.6%+86.4%-84.8%-2.8%
1Y+25.5%+115.1%-89.6%+18.7%
3Y+49.3%+14.6%+34.6%+46.8%
5Y+46.7%-8.8%+55.4%+47.0%
All+46.7%-8.5%+55.2%+47.0%

Cumulative growth

Daily Returns

Daily percentage return beside DAR.

Daily Out/Under-Performance

Portfolio return minus DAR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded DAR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling